Back

Mortality rates and cause of mortality in patients with mildly elevated pulmonary pressures versus PH: insights from the retrospective EVIDENCE-PAH study

26 August 2022 (16:15 - 17:00)
Organised by:
Congress Presentation Part of: Modulators of pulmonary vascular function: exercise, hypoxia, PAWP and breathing Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Nina Karia

Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Right heart adaptation during exercise in pulmonary arterial hypertension and in pulmonary hypertension due to heart failure with preserved ejection fraction
Doctor C. Baratto (Bergamo, IT)
Abstract Slides
Presentation thumbnail
Ventilatory inefficiency predicts abnormal hemodynamic response to exercise in chronic thromboembolic disease
Mr S. Huertas Nieto (Santa Cruz de Tenerife, ES)
Abstract Slides
Presentation thumbnail
Reappraisal of echocardiographic algorithm in predicting the pulmonary hypertension redefined by updated pulmonary artery mean pressure treshold
Doctor S. Tanyeri (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Chronic thromboembolic pulmonary hypertension and left ventricular filling pressures
Professor I. Lang (Vienna, AT)
Abstract Slides
Presentation thumbnail
Role of combined exercise stress echocardiography and cardiopulmonary exercise test in chronic thromboembolic disease
Doctor K. Jeon (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
Modulators of pulmonary vascular function: exercise, hypoxia, PAWP and breathing

The Event

Event poster

ESC Congress 2022

26 August 2022 16:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources